- Home
- NMT vs ZTEK Comparison
NMT vs ZTEK Comparison
Compare NMT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- ZTEK
- Stock Information
- Founded
- NMT 1993
- ZTEK 2008
- Country
- NMT United States
- ZTEK Canada
- Employees
- NMT N/A
- ZTEK N/A
- Industry
- NMT Finance/Investors Services
- ZTEK Major Chemicals
- Sector
- NMT Finance
- ZTEK Industrials
- Exchange
- NMT Nasdaq
- ZTEK Nasdaq
- Market Cap
- NMT 110.6M
- ZTEK 122.0M
- IPO Year
- NMT N/A
- ZTEK N/A
- Fundamental
- Price
- NMT $11.77
- ZTEK $0.92
- Analyst Decision
- NMT
- ZTEK
- Analyst Count
- NMT 0
- ZTEK 0
- Target Price
- NMT N/A
- ZTEK N/A
- AVG Volume (30 Days)
- NMT 19.1K
- ZTEK 43.5K
- Earning Date
- NMT 01-01-0001
- ZTEK 02-28-2025
- Dividend Yield
- NMT 3.21%
- ZTEK N/A
- EPS Growth
- NMT N/A
- ZTEK N/A
- EPS
- NMT N/A
- ZTEK N/A
- Revenue
- NMT N/A
- ZTEK $44,936.00
- Revenue This Year
- NMT N/A
- ZTEK N/A
- Revenue Next Year
- NMT N/A
- ZTEK N/A
- P/E Ratio
- NMT N/A
- ZTEK N/A
- Revenue Growth
- NMT N/A
- ZTEK 92.38
- 52 Week Low
- NMT $9.05
- ZTEK $0.50
- 52 Week High
- NMT $10.93
- ZTEK $1.34
- Technical
- Relative Strength Index (RSI)
- NMT 46.08
- ZTEK 40.62
- Support Level
- NMT $11.85
- ZTEK $0.88
- Resistance Level
- NMT $11.89
- ZTEK $0.99
- Average True Range (ATR)
- NMT 0.09
- ZTEK 0.10
- MACD
- NMT -0.02
- ZTEK -0.01
- Stochastic Oscillator
- NMT 12.96
- ZTEK 34.48
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.